drugset / Trial / NCT01289353

Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer

NCT01289353 ↗

Phase 1/2 Completed 92 enrolled NYU Langone Health
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and effectiveness of a combination of chemotherapy and radiotherapy in breast cancer patients after breast surgery.

Timeline

Start
2009-03-06
Primary completion
2019-07-08
Completion
2019-07-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 2 unknown Intravenous

Indications